Bank of New York Mellon Corp - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$51,000
-82.9%
105,414
-52.8%
0.00%
Q1 2019$299,000
+26.2%
223,141
+6.6%
0.00%
Q4 2018$237,000
-59.1%
209,353
-0.3%
0.00%
Q3 2018$580,000
-44.0%
210,003
-27.6%
0.00%
Q2 2018$1,035,000
+40.2%
289,970
+20.5%
0.00%
Q1 2018$738,000
-50.1%
240,638
+2.5%
0.00%
Q4 2017$1,480,000
-8.0%
234,864
-0.2%
0.00%
Q3 2017$1,609,000
+16.3%
235,309
+21.2%
0.00%
Q2 2017$1,384,000
-19.8%
194,144
+3.3%
0.00%
Q1 2017$1,726,000
+135.8%
187,897
+3.4%
0.00%
Q4 2016$732,000
+28.6%
181,783
+22.5%
0.00%
Q3 2016$569,000
-22.9%
148,369
-13.5%
0.00%
Q2 2016$738,000
-21.3%
171,552
-15.4%
0.00%
Q1 2016$938,000
-42.3%
202,667
+25.1%
0.00%
Q4 2015$1,626,000
+36.5%
162,039
+1.5%
0.00%
Q3 2015$1,191,000
-89.1%
159,678
-30.7%
0.00%
-100.0%
Q2 2015$10,937,000
+48.1%
230,528
+14.4%
0.00%
+50.0%
Q1 2015$7,383,000
+2.5%
201,507
+11.1%
0.00%0.0%
Q4 2014$7,204,000
+146.5%
181,424
+23.8%
0.00%
+100.0%
Q3 2014$2,923,000
+22.6%
146,541
-17.1%
0.00%
Q2 2014$2,384,000
+226.6%
176,712
+163.6%
0.00%
Q1 2014$730,000
+1.0%
67,036
+25.4%
0.00%
Q4 2013$723,000
-2.6%
53,477
-18.0%
0.00%
Q3 2013$742,000
+222.6%
65,252
+99.2%
0.00%
Q2 2013$230,00032,7600.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2013
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 300,000$1,209,0000.23%
Rock Springs Capital Management LP 698,000$2,813,0000.19%
Eventide Asset Management 600,000$2,418,0000.16%
Teza Capital Management LLC 14,369$58,0000.08%
Candriam S.C.A. 374,000$1,507,0000.04%
R&F Capital Advisors LP 23,778$96,0000.03%
Tekla Capital Management LLC 192,322$775,0000.03%
Sunbelt Securities, Inc. 6,000$24,180,0000.03%
DOW CHEMICAL CO /DE/ 65,000$249,0000.03%
CANADA PENSION PLAN INVESTMENT BOARD 1,654,100$6,666,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders